Ad is loading...
GQLVX
Price
$14.57
Change
-$0.11 (-0.75%)
Updated
Nov 15 closing price
VIVAX
Price
$68.72
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

GQLVX vs VIVAX

Header iconGQLVX vs VIVAX Comparison
Open Charts GQLVX vs VIVAXBanner chart's image
Glenmede Quant US Large Cap Value Equity
Price$14.57
Change-$0.11 (-0.75%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.72
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
GQLVX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GQLVX vs. VIVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQLVX is a Buy and VIVAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. GQLVX (2.14M). VIVAX pays higher dividends than GQLVX: VIVAX (2.25) vs GQLVX (1.65). GQLVX was incepted earlier than VIVAX: GQLVX (7 years) vs VIVAX (32 years). GQLVX is a more actively managed with annual turnover of: 81.00 vs. VIVAX (10.00). GQLVX has a lower initial minimum investment than VIVAX: GQLVX (0) vs VIVAX (3000). VIVAX (25.55) and GQLVX (24.86) have marching annual gain over last year. VIVAX return over 5 years is better than : 50.81 vs. GQLVX (48.10).
GQLVXVIVAXGQLVX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years32 years-
Gain YTD16.12517.91290%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.14M184B0%
Annual Yield % from dividends1.652.2573%
Returns for 1 year24.8625.5597%
Returns for 3 years14.6021.5868%
Returns for 5 years48.1050.8195%
Returns for 10 yearsN/A110.46-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POR46.650.76
+1.66%
Portland General Electric Company
UMH19.16-0.17
-0.85%
UMH Properties
YQ1.86-0.02
-1.11%
17 Education & Technology Group
FICO2261.00-62.17
-2.68%
Fair Isaac Corp
PSTX2.76-0.45
-14.02%
Poseida Therapeutics